A Study of TL-925 as a Treatment for Dry Eye Disease

NCT05745064 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: TL-925
DRUG: Placebo

Sponsor

Telios Pharma, Inc.